Especially in patients with severe generalized pruritus who do not respond to standard antipruritic treatments, the use of DPP-4 inhibitors, one class of oral antidiabetic agents, should be questioned and all medications used by the patient should be reviewed. Here, DPP4 is linked to Pruritus.